The proposed programs
AUTOIMMUNITY | ||||
Short title |
Evaluated antibodies | Format | Order number | Time period |
AChR Autoantibodies against acetylcholine receptors (AChR) |
AChR [IgG] | 1 set of specimen 2x200µl 2 sets of specimen 2x400µl |
QV 1435-0202 QV 1435-0204-1 |
2 |
ANA Autoantibodies against cell nuclei |
Cell nuclei, centromeres, CENP A, CENP B, dsDNA, nucleosomes, ribosomal P protein, RNP/Sm, RNP, Scl-70, Sm, SS-A, SS-B [IgG] | 1 set of specimen 2x400µl | QV 1510-0204 | 1 |
ANCA Autoantibodies against granulocytes |
ANCA, MPO, PR3 [IgG] | 1 set of specimen 2x200µl 2 sets of specimen 2x400µl |
QV 1200-0202 QV 1200-0204-1 |
2 |
CCP Antibodies against CCP |
CCP [IgG] | 1 set of specimen 2x200µl 2 sets of specimen 2x400µl |
QV 1505-0202 QV 1505-0204-1 |
2 |
Celiac disease Antibodies against tissue transglutaminase (endomysium) and gliadin |
tTG, EMA, Gliadin [IgA, IgG] |
1 set of specimen 2x200µl 2 sets of specimen 2x400µl |
QV 1913-0202 QV 1913-0204-1 |
2 |
Diabetes Autoantibodies in Diabetes |
GAD, Islet cells, IA2, Zinc transporter 8 [IgG] | 1 set of specimen 2x200µl 2 sets of specimen 2x400µl |
QV 1020-0202 QV 1020-0204-1 |
2 |
Kidney Antibodies in autoimmune kidney diseases |
GBM, PLA2R, THSD7A [IgG] | 1 set of specimen 2x200µl 2 sets of specimen 2x400µl |
QV 1250-0202 QV 1250-0204-1 |
2 |
Liver Antibodies in autoimmune liver diseases |
AMA, ASMA, F-actin, gp210, LC-1, LKM-1, M2, nuclear dots, nuclear membrane, SLA/LP, Sp100 [IgG, IgAGM] | 1 set of specimen 2x200µl 2 sets of specimen 2x400µl |
QV 1300-0202 QV 1300-0204-1 |
1 |
Myopathies
Antibodies in autoimmune Myopathies
|
cN-1A, EJ, Jo-1, Ku, Mi-2, Mi-2a, Mi-2b, OJ, PL-7, PL-12, PM-Scl, SRP [IgG] | 1 set of specimen 2x200µl 2 sets of specimen 2x400µl |
QV 1530-0202 QV 1530-0204-1 |
1 |
Neuronals
Autoantibodies against neuronal antigens
|
Amphiphysin, Aquaporin 4, CASPR2, CV2, GAD, Hu, LGI1, Ma/Ta, MOG, NMDA receptor, Recoverin, Ri, SOX1, Titin, Yo, Zic4 [IgG, IgAGM] |
1 set of specimen 2x200µl 2 sets of specimen 2x400µl |
QV 1111-0202 QV 1111-0204-1 |
2 |
PA
Autoantibodies in pernicious anaemia
|
Intrinsic Faktor, Parietalzellen (PCA) [IgG] | 1 set of specimen 2x200µl 2 sets of specimen 2x400µl |
QV 1360-0202 QV 1360-0204-1 |
2 |
Phospholipids
Autoantibodies against phospholipids
|
Cardiolipin [IgG, IgM, IgAGM], ß2-Glykoprotein [IgG, IgM, IgAGM] |
1 set of specimen 2x150µl 2 sets of specimen 2x300µl |
QV 1632-0201 QV 1632-0203-1 |
2 |
Skin
Autoantibodies against structural proteins of the skin
|
BP 180, BP 230, collagen type VII, desmoglein 1 and 3, desmosomes, epidermal basement membrane [IgG] | 1 set of specimen 2x200µl 2 sets of specimen 2x400µl |
QV 1501-0202 QV 1501-0204-1 |
2 |
Thyroid gland
Autoantibodies against thyroid gland
|
TG, TPO, TRAk [IgG] |
1 set of specimen 2x300µl 2 sets of specimen 2x600µl |
QV 1010-0203 QV 1010-0206-1 |
2 |
INFECTIOUS SEROLOGY | ||||
Short title |
Evaluated antibodies | Format | Order number | Time period |
Borrelia
Antibodies against Borrelia burgdorferi sensu lato
|
Borrelia [IgG, IgM], serological diagnosis |
1 set of specimen 2x250µl 2 sets of specimen 2x500µl |
QV 2132-0202 QV 2132-0205-1 |
1 |
Chikungunya Virus
Antibodies against Chikungunya Virus
|
Chikungunya-Virus [IgG, IgM] |
1 set of specimen 2x300µl 2 sets of specimen 2x600µl |
QV 293a-0203 QV 293a-0206-1 |
3 |
Dengue Virus
Antibodies against Dengue-Virus
|
Dengue virus [IgG, IgM], Dengue virus NS1 antigen |
1 set of specimen 2x300µl 2 sets of specimen 2x600µl |
QV 266a-0203 QV 266a-0206-1 |
3 |
EBV
Antibodies against Epstein-Barr Virus
|
EBV-CA [IgG, IgM], EBNA-1 [IgG], avidity, serological diagnosis | 1 set of specimen 2x200µl 2 sets of specimen 2x400µl |
QV 2790-0202 QV 2790-0204-1 |
1 |
HEV
Antibodies against Hepatitis-E Virus
|
HEV [IgG, IgM, IgAGM] | 1 set of specimen 2x200µl 2 sets of specimen 2x400µl |
QV 2525-0202 QV 2525-0204-1 |
1 |
HSV
Antibodies against Herpes simplex-Virus
|
HSV 1, HSV 2, HSV-1/2 [IgG, IgM] | 1 set of specimen 2x200µl 2 sets of specimen 2x400µl |
QV 2531-0202 QV 2531-0204-1 |
1 |
Measles virus
Antibodies against measles virus
|
Measles vius [IgG, IgM] | 1 set of specimen 2x200µl 2 sets of specimen 2x400µl |
QV 2610-0202 QV 2610-0204-1 |
1 |
Parvovirus B19 Antibodies against Parvovirus B19 |
Parvovirus B 19 [IgG, IgM] | 1 set of specimen 2x200µl 2 sets of specimen 2x400µl |
QV 2580-0202 QV 2580-0204-1 |
1 |
SARS CoV-2
Antibodies against SARS CoV-2
|
SARS-CoV-2 (NCP), SARS CoV-2 (S1) [IgG], neutralizing antibodies | 1 set of specimen 2x200µl 2 sets of specimen 2x400µl |
QV 2606-0202 QV 2606-0204-1 |
1 |
Zika virus
Antibodies against Zika virus
|
Zika virus [IgG, IgM, IgA, IgAM] | 1 set of specimen 2x300µl 2 sets of specimen 2x600µl |
QV 2668-0203 QV 2668-0206-1 |
3 |
ALLERGOLOGY | ||||
Short title |
Evaluated antibodies | Format | Order number | Time period |
Molecular allergology
Molecular Allergology specific IgE
|
Specific IgE (at least 6 different per distribution) | 1 set of specimen 2x1000µl | QV 3002-0210 | 4 |
Specific IgE
Allergology specific IgE
|
Specific IgE (at least 6 different per distribution) | 1 set of specimen 2x1000µl | QV 3000-0210 | 1 |
Total IgE
Allergology total IgE
|
Total IgE | 1 set of specimen 2x500µl 2 sets of specimen 2x1000µl |
QV 3840-0205
QV 3840-0210-1
|
1 |
Deadline for registration/ deregistration | Half-year | Date of shipment | Deadline | |
Time period 1 | November 30, 2023 June 30, 2024 |
I II |
March 12, 2024 September 10, 2024 |
April 9, 2024 October 8, 2024 |
Time period 2 | November 30, 2023 June 30, 2024 |
I II |
April 23, 2024 October 15, 2024 |
May 21, 2024 November 12, 2024 |
Time period 3 | November 30, 2023 | I | March 12, 2024 | April 9, 2024 |
Time period 4 | June 30, 2024 | II | September 10, 2024 | October 8,2024 |
DATES QAS |
DATES QAS |
SCHEME |
ORDER |
FORMAT |
---|---|---|---|---|
Registration until: |
Registration until: |
Autoantibodies against cell nuclei Cell nuclei, centromeres, CENP A, CENP B, dsDNA, nucleosomes, ribosomal P protein, RNP/Sm, RNP, Scl-70, Sm, SS-A, SS-B [IgG] |
QV 1510-0204 | 1 set of specimen 2x400μl |
Antibodies in autoimmune Myopathies cN-1A, EJ, Jo-1, Ku, Mi-2, Mi-2β, Mi-2β, OJ, PL-7, PL-12, PMScl, SRP [IgG] |
QV 1530-0202 | 1 set of specimen 2x200μl | ||
QV 1530-0204-1 | 2 sets of specimen 2x400μl | |||
Antibodies in autoimmune liver diseases AMA, ASMA, F-actin, gp210, LC-1, LKM-1, M2, nuclear dots, nuclear membrane, SLA/LP, Sp100 [IgG, IgAGM] |
QV 1300-0202 | 1 set of specimen 2x200μl | ||
QV 1300-0204-1 | 2 sets of specimen 2x400μl | |||
Registration until: |
Registration until: |
Autoantibodies against thyroid gland TG, TPO, TRAk [IgG] |
QV 1010-0203 | 1 set of specimen 2x300μl |
QV 1010-0206-1 | 2 sets of specimen 2x600μl | |||
Autoantibodies against neuronal antigenes Amphiphysin, Aquaporin 4, CASPR2, CV2, GAD, Hu, LGI1, Ma/Ta, MOG, NMDA-Rezeptor, Recoverin, Ri, SOX1, Titin, Yo, Zic4 [IgG, IgAGM] |
QV 1111-0202 | 1 set of specimen 2x200μl | ||
QV 1111-0204-1 | 2 sets of specimen 2x400μl | |||
Autoantibodies against granulocytes ANCA, MPO, PR3 [IgG] |
QV 1200-0202 | 1 set of specimen 2x200μl | ||
QV 1200-0204-1 | 2 sets of specimen 2x400μl | |||
Autoantibodies against structural proteins of the skin BP 180, BP 230, collagen type VII, desmoglein 1 and 3, desmosomes, epidermal basement membrane [IgG] |
QV 1501-0202 | 1 set of specimen 2x200μl | ||
QV 1501-0204-1 | 2 sets of specimen 2x400μl | |||
Antibodies against CCP CCP [IgG] |
QV 1505-0202 | 1 set of specimen 2x200μl | ||
QV 1505-0204-1 | 2 sets of specimen 2x400μl | |||
Autoantibodies against phospholipids Cardiolipin [IgG, IgM, IgAGM], ß2 glykoprotein [IgG, IgM, IgAGM] |
QV 1632-0201 | 1 set of specimen 2x150μl | ||
QV 1632-0203-1 | 2 sets of specimen 2x300μl | |||
Antibodies against tissue transglutaminase (endomysium) and gliadin tTG, EMA, Gliadin [IgA, IgG] |
QV 1913-0202 | 1 set of specimen 2x200μl | ||
QV 1913-0204-1 | 2 sets of specimen 2x400μl | |||
Antibodies in autoimmune kidney diseases GBM, PLA2R, THSD7A [IgG] |
QV 1250-0202 | 1 set of specimen 2x200μl | ||
QV 1250-0204-1 | 2 sets of specimen 2x400μl | |||
Autoantibodies in pernicious anaemia |
QV 1360-0202 | 1 set of specimen 2x200μl | ||
QV 1360-0204-1 | 2 sets of specimen 2x400μl | |||
Autoantibodies against acetylcholine receptors AchR [IgG] | QV 1435-0202 | 1 set of specimen 2x200μl | ||
QV 1435-0204-1 | 2 sets of specimen 2x400μl | |||
Autoantibodies in Diabetes mellitus |
QV 1020-0202 | 1 set of specimen 2x200μl | ||
QV 1020-0204-1 | 2 sets of specimen 2x400μl | |||
Registration until: |
Registration until: |
Antibodies against Borrelia burgdorferi sensu lato [IgG, IgM, serological diagnosis] |
QV 2132-0202 | 1 set of specimen 2x250μl |
QV 2132-0205-1 | 2 sets of specimen 2x500μl | |||
Antibodies against Herpes-simplex-Virus HSV 1, HSV 2, HSV-1/2 [IgG, IgM] |
QV 2531-0202 | 1 set of specimen 2x200μl | ||
QV 2531-0204-1 | 2 sets of specimen 2x400μl | |||
Antibodies against Parvovirus-B19 [IgG, IgM] |
QV 2580-0202 | 1 set of specimen 2x200μl | ||
QV 2580-0204-1 | 2 sets of specimen 2x400μl | |||
Antibodies against Epstein-Barr-Virus EBV-CA [IgG, IgM], EBNA-1 [IgG], avidity, serological diagnosis |
QV 2790-0202 | 1 set of specimen 2x200μl | ||
QV 2790-0204-1 | 2 sets of specimen 2x400μl | |||
Antibodies against Hepatitis-E-Virus [IgG, IgM, IgAGM] |
QV 2525-0202 | 1 set of specimen 2x200μl | ||
QV 2525-0204-1 | 2 sets of specimen 2x400μl | |||
Antibodies against SARS-CoV-2 NCP, S1-based, neutralizing antibodies |
QV 2606-0202 | 1 set of specimen 2x200μl | ||
QV 2606-0204-1 | 2 sets of specimen 2x400μl | |||
Antibodies against measles virus |
QV 2610-0202 | 1 set of specimen 2x200μl | ||
QV 2610-0204-1 | 2 sets of specimen 2x400μl | |||
Registration until: |
No shipment | Antibodies against Zika virus [IgG, IgM, IgA, IgAM] |
QV 2668-0203 | 1 set of specimen 2x300μl |
QV 2668-0206-1 | 2 sets of specimen 2x600μl | |||
Antibodies against Dengue virus Dengue virus [IgG, IgM], Dengue virus NS1 antigen |
QV 266a-0203 | 1 set of specimen 2x300μl | ||
QV 266a-0206-1 | 2 sets of specimen 2x600μl | |||
Antibodies against Chikungunya virus [IgG, IgM] |
QV 293a-0203 | 1 set of specimen 2x300μl | ||
QV 293a-0206-1 | 2 sets of specimen 2x600μl | |||
Registration until: |
Registration until: |
Allergology total IgE |
QV 3840-0205 | 1 set of specimen 2x500μl |
QV 3840-0210-1 | 2 sets of specimen 2x1000μl | |||
Allergology Specific IgE (at least 6 different per distribution) |
QV 3000-0210 | 1 set of specimen 2x1000μl | ||
No shipment |
Registration until: |
Molecular Allergology Specific IgE (at least 6 different per distribution) |
QV 3002-0210 | 1 set of specimen 2x1000μl |
* The program is newly introduced by EUROIMMUN
DATES QAS |
DATES QAS |
SCHEME |
ORDER |
FORMAT |
---|---|---|---|---|
Registration until: |
Registration until: |
Autoantibodies against cell nuclei |
QV 1510-0204 | 1 set of specimen 2x400μl |
Antibodies in autoimmune Myopathies cN-1A, EJ, Ku, Jo-1, Mi-2, Mi-2α, Mi-2β, OJ, PM-Scl, PL-7, PL-12, SRP |
QV 1530-0202 | 1 set of specimen 2x200μl | ||
QV 1530-0204-1 | 2 sets of specimen 2x400μl | |||
Antibodies in autoimmune liver diseases AMA, ASMA, F-actin, gp210, LC-1, LKM-1, M2, nuclear dots, nuclear membrane, SLA/LP, Sp100 |
QV 1300-0202 | 1 set of specimen 2x200μl | ||
QV 1300-0204-1 | 2 sets of specimen 2x400μl | |||
Registration until: |
Registration until: |
Autoantibodies against thyroid gland TG, TPO, TRAb |
QV 1010-0203 | 1 set of specimen 2x300μl |
QV 1010-0206-1 | 2 sets of specimen 2x600μl | |||
Autoantibodies against neuronal antigenes Amphiphysin, Aquaporin 4, CASPR2, CV2, GAD, Hu, LGI1, Ma/Ta, NMDA-Receptor, Ri, Yo |
QV 1111-0202 | 1 set of specimen 2x200μl | ||
QV 1111-0204-1 | 2 sets of specimen 2x400μl | |||
Autoantibodies against granulocytes ANCA, MPO, PR3 |
QV 1200-0202 | 1 set of specimen 2x200μl | ||
QV 1200-0204-1 | 2 sets of specimen 2x400μl | |||
Autoantibodies against structural proteins of the skin BP 180, BP 230, desmoglein 1 und 3, desmosomes, epidermal basement membrane |
QV 1501-0202 | 1 set of specimen 2x200μl | ||
QV 1501-0204-1 | 2 sets of specimen 2x400μl | |||
Antibodies against CCP | QV 1505-0202 | 1 set of specimen 2x200μl | ||
QV 1505-0204-1 | 2 sets of specimen 2x400μl | |||
Autoantibodies against phospholipids Cardiolipin (IgG, IgM, IgAGM); ß2-Glykoprotein (IgG, IgM, IgAGM) |
QV 1632-0201 | 1 set of specimen 2x150μl | ||
QV 1632-0203-1 | 2 sets of specimen 2x300μl | |||
Antibodies against tissue transglutaminase (endomysium) and gliadin (IgA, IgG) |
QV 1913-0202 | 1 set of specimen 2x200μl | ||
QV 1913-0204-1 | 2 sets of specimen 2x400μl | |||
Antibodies in autoimmune kidney diseases GBM, PLA2R, THSD7A |
QV 1250-0202 | 1 set of specimen 2x200μl | ||
QV 1250-0204-1 | 2 sets of specimen 2x400μl | |||
Autoantibodies in pernicious anaemia |
QV 1360-0202 | 1 set of specimen 2x200μl | ||
QV 1360-0204-1 | 2 sets of specimen 2x400μl | |||
Autoantibodies against acetylcholine receptors (AChR) | QV 1435-0202 | 1 set of specimen 2x200μl | ||
QV 1435-0204-1 | 2 sets of specimen 2x400μl | |||
Registration until: |
Registration until: |
Antibodies against Borrelia burgdorferi sensu lato (IgG, IgM, serological diagnosis) |
QV 2132-0202 | 1 set of specimen 2x250μl |
QV 2132-0205-1 | 2 sets of specimen 2x500μl | |||
Antibodies against Herpes-simplex-Virus HSV 1, HSV 2, HSV 1/2 (IgG, IgM) |
QV 2531-0202 | 1 set of specimen 2x200μl | ||
QV 2531-0204-1 | 2 sets of specimen 2x400μl | |||
Antibodies against Parvovirus-B19 (IgG, IgM) |
QV 2580-0202 | 1 set of specimen 2x200μl | ||
QV 2580-0204-1 | 2 sets of specimen 2x400μl | |||
Antibodies against Epstein-Barr-Virus EBV-CA (IgG, IgM), EBNA-1 (IgG), Avidity, serological diagnosis |
QV 2790-0202 | 1 set of specimen 2x200μl | ||
QV 2790-0204-1 | 2 sets of specimen 2x400μl | |||
Antibodies against Hepatitis-E-Virus (IgG, IgM, IgAGM) |
QV 2525-0202 | 1 set of specimen 2x200μl | ||
QV 2525-0204-1 | 2 sets of specimen 2x400μl | |||
Antibodies against SARS-CoV-2 NCP, S1-based, neutralizing antibodies (IgG) |
QV 2606-0202 | 1 set of specimen 2x200μl | ||
QV 2606-0204-1 | 2 sets of specimen 2x400μl | |||
Registration until: November 30, 2021 Shipment: March 15, 2022 Deadline: April 12, 2022 |
No shipment | Antibodies against Zika virus (IgG, IgM, IgA, IgAM) |
QV 2668-0203 | 1 set of specimen 2x300μl |
QV 2668-0206-1 | 2 sets of specimen 2x600μl | |||
Antibodies against Dengue virus (IgG, IgM), Dengue virus NS 1 antigen |
QV 266a-0203 | 1 set of specimen 2x300μl | ||
QV 266a-0206-1 | 2 sets of specimen 2x600μl | |||
Antibodies against Chikungunya virus (IgG, IgM) |
QV 293a-0203 | 1 set of specimen 2x300μl | ||
QV 293a-0206-1 | 2 sets of specimen 2x600μl | |||
Registration until: |
Registration until: |
Allergology total IgE |
QV 3840-0205 | 1 set of specimen 2x500μl |
QV 3840-0210-1 | 2 sets of specimen 2x1000μl | |||
Allergology specific IgE |
QV 3000-0210 | 1 set of specimen 2x1000μl | ||
Molecular Allergology specific IgE |
QV 3002-0210 | 1 set of specimen 2x1000μl |